Our platform
Our versatile biosynthesis platform enables to produce classic psychedelics as well as new chemical entities with desired properties.
License to work with Schedule I substances
R&D Laboratory upgrade
Psilocybin biosynthesis technology development in yeasts
Versatile biosynthesis platform for various classic and next generation psychedelic compounds
API grade Psilocybin is ready for market
Identify novel psychedelic candidates and build the pipeline of next-gen molecules
Collaboration with Research institutions for novel indications
Manufacturing additional drug products for Clinical research